Holen Sie sich die Stockscreener-App
47.32
3.41%
-1.67
Schlusskurs vom Vortag:
$48.99
Offen:
$49.04
24-Stunden-Volumen:
626.51K
Relative Volume:
0.46
Marktkapitalisierung:
$5.67B
Einnahmen:
$47.30M
Nettoeinkommen (Verlust:
$-408.73M
KGV:
-13.19
EPS:
-3.5865
Netto-Cashflow:
$-303.86M
1W Leistung:
-0.73%
1M Leistung:
-13.96%
6M Leistung:
+6.72%
1J Leistung:
+27.72%
1-Tages-Spanne:
$46.92
$49.33
1-Wochen-Bereich:
$46.92
$50.12
52-Wochen-Spanne:
$27.07
$58.49
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Firmenname
Scholar Rock Holding Corp
Sektor
Branche
Telefon
857-259-3860
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Compare SRRK vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
47.32 | 5.86B | 47.30M | -408.73M | -303.86M | -3.5865 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Eingeleitet | Canaccord Genuity | Buy |
| 2026-01-09 | Eingeleitet | Citigroup | Buy |
| 2025-11-18 | Eingeleitet | Wolfe Research | Outperform |
| 2025-10-09 | Eingeleitet | BofA Securities | Buy |
| 2025-09-17 | Eingeleitet | Barclays | Overweight |
| 2025-09-15 | Eingeleitet | Leerink Partners | Outperform |
| 2025-08-21 | Fortgesetzt | Jefferies | Buy |
| 2025-07-30 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-07-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-26 | Bestätigt | H.C. Wainwright | Buy |
| 2024-10-07 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-28 | Eingeleitet | Raymond James | Strong Buy |
| 2023-10-25 | Hochstufung | Jefferies | Hold → Buy |
| 2023-04-03 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-07-12 | Eingeleitet | Truist | Buy |
| 2022-03-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-22 | Herabstufung | Jefferies | Buy → Hold |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-06 | Eingeleitet | JP Morgan | Overweight |
| 2020-03-12 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
Scholar Rock Holding Corporation $SRRK Shares Bought by Eagle Health Investments LP - MarketBeat
Scholar Rock stock advances on buying interest after oversold momentum and technical recovery - Traders Union
Scholar Rock Holding Corp (SRRK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Scholar Rock Holding Corp (SRRK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SRRK|Scholar Rock Holding Corp|Price:48.930|Chg%:+1.260 - TradingKey
Scholar Rock Holding Corp (SRRK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Scholar Rock Holding Corp (SRRK) Cash Flow - TradingKey
SRRK|Scholar Rock Holding Corp|Price:49.820|Chg%:+2.150 - TradingKey
SRRK|Scholar Rock Holding Corp|Price:47.750|Chg%:-1.180 - TradingKey
Scholar Rock Holding Corp (SRRK) Balance Sheet - TradingKey
TradingKey - TradingKey
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
SRRK|Scholar Rock Holding Corp|Price:47.670|Chg%:-1.810 - TradingKey
ETFs Investing in Scholar Rock Holding Corp. Stocks - TradingView
Scholar Rock Holding Corp (SRRK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
D.A. Davidson & CO. Purchases New Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
SRRK Stock Surges To Near Five-Year Highs – Here’s Why Analysts Are Bullish About Its Latest FDA Filing - Stocktwits
SRRK Reiterated by Wedbush -- Price Target Maintained at $58 - GuruFocus
Scholar Rock says EU opinion on SMA drug may be pushed to later in 2026 - Reuters
Scholar Rock (NASDAQ:SRRK) Receives Outperform Rating from Wedbush - MarketBeat
Scholar Rock Holding Corporation (SRRK): Investor Outlook with a Promising 17.08% Upside - DirectorsTalk Interviews
Law firm investigates Scholar Rock officers for possible shareholder duty breaches - Pluang
Scholar Rock awaits FDA decision on apitegromab EU approval By Investing.com - Investing.com Nigeria
Scholar Rock awaits FDA decision on apitegromab EU approval - Investing.com India
SMA treatment review in Europe awaits FDA facility classification - Stock Titan
Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (CHMP) Opinion for Apitegromab Marketing Authorisation Application (MAA) for Spinal Muscular Atrophy (SMA) - Yahoo Finance
Jennison Associates LLC Buys 545,304 Shares of Scholar Rock Holding Corporation $SRRK - MarketBeat
11 New Hires Get Scholar Rock Equity Awards Covering 118,586 Shares - Stock Titan
Scholar Rock (SRRK) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Scholar Rock (SRRK) Q3 2025 earnings summary - Quartr
Scholar Rock schedules Aug. 6 webcast before markets open - Stock Titan
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH - RTTNews
Scholar Rock Holding Corporation $SRRK Holdings Raised by Candriam S.C.A. - MarketBeat
SRRK Stock Prediction: Huge SMA Drug Launch Breakthrough? (2026 Alert) Marcus Smart (7wRYet6o9c) - Mshale
Scholar Rock Holding (SRRK) Rallies As Pipeline Story Meets A Fair Value Question - simplywall.st
SG Americas Securities LLC Cuts Stake in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock (SRRK) Q1 2025 earnings summary - Quartr
Inside THNR: A Leaner Approach to Weight Loss Investing - ETF Database
Scholar Rock stock hits 52-week high at 56.56 USD By Investing.com - Investing.com Canada
Scholar Rock stock hits 52-week high at 56.56 USD - Investing.com
Form 144 Scholar Rock Holding Corp. For: 6 July By Investing.com - Investing.com Canada
Scholar Rock (NASDAQ: SRRK) director 10b5-1 sale of 3,053 shares - Stock Titan
Scholar Rock (SRRK) director’s 3,053-share sale tied to RSU tax obligations - Stock Titan
Scholar Rock (SRRK) director Katie Peng sells 5,446 shares under 10b5-1 tax plan - Stock Titan
Mohammed Qatanani to sell 11,704 SRRK shares (NASDAQ: SRRK) - Stock Titan
SRRKScholar Rock Holding Corp Volatility & Greeks - Finviz
[144] Scholar Rock Holding Corp SEC Filing - Stock Titan
Form 144 Scholar Rock Holding Corp. For: 1 July By Investing.com - Investing.com India
SRRK (NASDAQ: SRRK) files Rule 144 notice to sell 5,446 shares via J.P. Morgan - Stock Titan
Pictet Asset Management Holding SA Cuts Stake in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Finanzdaten der Scholar Rock Holding Corp-Aktie (SRRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Scholar Rock Holding Corp-Aktie (SRRK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gilman Michael | Director |
Jul 01 '26 |
Sale |
53.87 |
2,544 |
137,058 |
59,511 |
| Burow Kristina | Director |
Jul 01 '26 |
Sale |
53.74 |
3,053 |
164,064 |
114,657 |
| Reed Joshua | Director |
Jul 01 '26 |
Sale |
53.74 |
3,053 |
164,067 |
19,518 |
| Peng Katie | Director |
Jul 01 '26 |
Sale |
53.88 |
5,446 |
293,405 |
34,301 |
2.44%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):